Global relapsed or refractory diffuse large B cell lymphoma market is estimated to be valued at US$ 1,479.5 Mn in 2023 and is expected to exhibit a CAGR of 4.3% during the forecast period (2023-2030).
Figure 1. Global Relapsed or Refractory Diffuse Large B Cell Lymphoma Market Share (%), By Drug Type, 2023
Relapsed or Refractory Diffuse Large B-cell Lymphoma Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients